-
Ovarian Cancer Patients May Benefit from Novel Immunotherapy
Researchers claim immunotherapy may offer improved outcomes for patients experiencing HRP ovarian cancer. Read more
-
Novel Monoclonal Antibody Could Transform High-Risk Neuroblastoma Treatment
Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with... Read more
-
The Importance of Screening for Genitourinary Syndrome of Menopause
New recommendations suggest every woman should be screened, whether or not they bring it up during an exam. Read more
Endometriosis May Not Cause Preterm Births
New research found no difference in rates of preterm births after adjusting for other risk factors.
Ovarian Cancer Patients May Benefit from Novel Immunotherapy
Researchers claim immunotherapy may offer improved outcomes for patients experiencing HRP ovarian cancer.
Quest for Medical Therapy for Alzheimer’s Disease Continues
Clinical trials for disease-modifying therapy for Alzheimer’s disease are underway.
Novel Monoclonal Antibody Could Transform High-Risk Neuroblastoma Treatment
Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with high-risk neuroblastoma significantly enhanced response to treatment and improved survival. Their findings could be transformative if additional studies can produce similar results.
- 1 of 255
- next ›